Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, 410013, China.
Key Laboratory of State Administration of Traditional Chinese Medicine, Sunshine Lake Pharma Co., LTD, Dongguan, 523850, China.
J Ethnopharmacol. 2020 Oct 5;260:112969. doi: 10.1016/j.jep.2020.112969. Epub 2020 May 15.
Cordyceps sinensis is a traditional Chinese medicine. It is widely reported that Cordyceps sinensis has inhibitory effect on tumor growth and immunoregulation effect on macrophages. However, the exact mechanism of Cordyceps sinensis on macrophage polarization in tumor progression is not known.
We aimed to investigate the role of extracts of Cordyceps sinensis on macrophage polarization and its underlying mechanism in antitumor activity.
The 4T1 orthotopic xenograft mouse model and immunohistochemical staining were used to investigate the effect of Cordyceps sinensis on breast tumor and the change of the macrophages phenotype in the tumor, respectively. A 3D co-culture assay was used to confirm the activity in vitro. Measurement of cytokines and NO, quantitative real-time PCR and flow cytometry assays were used to investigate the effect of Cordyceps sinensis on the macrophage polarization in vitro. The mechanism of the effect of Cordyceps sinensis on macrophages was investigated by using western blot assays.
In the orthotopic mouse tumor model, Cordyceps sinensis inhibited the 4T1 tumor growth in a dose dependent manner, and the immunohistochemical staining analysis showed that there is a positive correlation between tumor growth inhibition and macrophage M1-like polarized phenotype. The cytokines and NO measurement, quantitative real-time PCR assay and flow cytometry assays confirmed that Cordyceps sinensis could promote macrophage differentiation toward the M1 phenotype. The 3D co-culture assay and western blot assay showed that Cordyceps sinensis could inhibit tumor growth by promoting macrophage polarization and enhance its activity by activating the NF-κB signaling pathway.
These findings suggest that Cordyceps sinensis could potently suppress TNBC progression by promoting M1 phenotypic differentiation of macrophages via activation NF-κB signaling pathway in tumor microenvironment.
冬虫夏草是一种中药。广泛报道称,冬虫夏草对肿瘤生长具有抑制作用,对巨噬细胞具有免疫调节作用。然而,冬虫夏草对肿瘤进展中巨噬细胞极化的确切机制尚不清楚。
我们旨在研究冬虫夏草提取物对巨噬细胞极化的作用及其在抗肿瘤活性中的潜在机制。
使用 4T1 原位异种移植小鼠模型和免疫组织化学染色分别研究冬虫夏草对乳腺癌的影响以及肿瘤中巨噬细胞表型的变化。使用 3D 共培养实验来确认其体外活性。通过测量细胞因子和 NO、实时定量 PCR 和流式细胞术实验来研究冬虫夏草对体外巨噬细胞极化的影响。通过 Western blot 实验来研究冬虫夏草对巨噬细胞的作用机制。
在原位小鼠肿瘤模型中,冬虫夏草呈剂量依赖性地抑制 4T1 肿瘤生长,免疫组织化学染色分析表明,肿瘤生长抑制与巨噬细胞 M1 样极化表型之间存在正相关。细胞因子和 NO 测量、实时定量 PCR 实验和流式细胞术实验证实,冬虫夏草可以促进巨噬细胞向 M1 表型分化。3D 共培养实验和 Western blot 实验表明,冬虫夏草可以通过促进巨噬细胞极化来抑制 TNBC 的进展,并通过激活 NF-κB 信号通路来增强其活性。
这些发现表明,冬虫夏草通过激活肿瘤微环境中的 NF-κB 信号通路,可促进 M1 表型的巨噬细胞分化,从而有力地抑制三阴性乳腺癌的进展。